Concepedia
Statistics
Publications
4
Citations
86
H-Index
Active since
2019
Affiliations
University of Amsterdam(Current)
Amsterdam University Medical Centers
Oncode Institute
The Netherlands Cancer Institute
Cancer Center Amsterdam
Yvonne J. Thus is an author at University of Amsterdam specializing in medicine, oncology, and cancer pharmacology.
Publications per year
2019–2023
High karyotypic complexity is an independent prognostic factor in patients with CLL treated with venetoclax combinations
Moritz Fürstenau, Yvonne J. Thus, Sandra Robrecht et al. · Blood · 2023 · 40 citations · Full text
Medicine, Hematology, Oncology +7
Inhibition of casein kinase 2 sensitizes mantle cell lymphoma to venetoclax through MCL-1 downregulation
Yvonne J. Thus, Martin F. M. de Rooij, Nathalie Swier et al. · Haematologica · 2022 · 20 citations · Full text
Medicine, Oncology, Pharmacology +15
A loss-of-adhesion CRISPR-Cas9 screening platform to identify cell adhesion-regulatory proteins and signaling pathways
Martin F. M. de Rooij, Yvonne J. Thus, Nathalie Swier et al. · Nature Communications · 2022 · 16 citations · Full text
Medicine, Oncology, Pharmacology +17
High-Complexity shRNA Libraries and PI3 Kinase Inhibition in Cancer: High-Fidelity Synthetic Lethality Predictions
Marsilius Mues, Laila Karra, Damià Romero–Moya et al. · Cell Reports · 2019 · 10 citations · Full text
Medicine, Oncology, Pharmacology +14
1–4 of 4